Literature DB >> 9711190

Uniqueness of pilsicainide in class Ic antiarrhythmics.

T Yamashita1, Y Murakawa, K Sezaki, N Hayami, M Inoue, E Fukui, M Omata.   

Abstract

Pilsicainide, a class Ic agent, is known to be an effective drug particularly for treating atrial tachyarrhythmias. However, its electrophysiological effects on the atrium have not been well studied. To characterize the electrophysiologic effects of pilsicainide on atrial myocytes in class Ic drugs, we examined the effects of this drug on membrane currents in single rabbit atrial myocytes using the tight-seal whole cell voltage-clamp technique. Under the current-clamp condition, pilsicainide did not affect the action potential duration at therapeutic ranges (< or = 3 microM) and slightly shortened it at higher concentrations (> or = 10 microM). These observations were quite different from those with other class Ic agents including flecainide and propafenone which prolong the atrial action potential duration. The drug did not affect the resting membrane potential. Under the voltage-clamp condition, pilsicainide inhibited the transient outward current (Ito) that is more prominent in the atrium than in the ventricle in a concentration-dependent manner. However, in contrast to other class Ic agents, the inhibition to Ito by pilsicainide was observed only at much higher concentrations (IC50-300 microM) and did not affect the inactivation time-course of Ito. Moreover, the drug (10 microM) did not significantly affect the Ca2+, delayed rectifier K+, inward rectifying K+, acetylcholine-induced K+ or ATP-sensitive K+ currents. From these results pilsicainide could be differentiated as a pure Na+ channel blocker from other class Ic agents with diverse effects on membrane currents and should be recognized accordingly in clinical situations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711190     DOI: 10.1536/ihj.39.389

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  3 in total

1.  Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide.

Authors:  J-F Desaphy; A Dipalma; T Costanza; C Bruno; G Lentini; C Franchini; Al George; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Flecainide ameliorates arrhythmogenicity through NCX flux in Andersen-Tawil syndrome-iPS cell-derived cardiomyocytes.

Authors:  Yusuke Kuroda; Shinsuke Yuasa; Yasuhide Watanabe; Shogo Ito; Toru Egashira; Tomohisa Seki; Tetsuhisa Hattori; Seiko Ohno; Masaki Kodaira; Tomoyuki Suzuki; Hisayuki Hashimoto; Shinichiro Okata; Atsushi Tanaka; Yoshiyasu Aizawa; Mitsushige Murata; Takeshi Aiba; Naomasa Makita; Tetsushi Furukawa; Wataru Shimizu; Itsuo Kodama; Satoshi Ogawa; Norito Kokubun; Hitoshi Horigome; Minoru Horie; Kaichiro Kamiya; Keiichi Fukuda
Journal:  Biochem Biophys Rep       Date:  2017-01-11

3.  Causes of abnormal Ca2+ transients in Guinea pig pathophysiological ventricular muscle revealed by Ca2+ and action potential imaging at cellular level.

Authors:  Hiroto Nishizawa; Takeshi Suzuki; Takao Shioya; Yuji Nakazato; Hiroyuki Daida; Nagomi Kurebayashi
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.